A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects
Clinical trial NCT03239379 · COMPLETED
Trial details
- NCT number
- NCT03239379
- Sponsor
- Bioniz Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-30
- Primary completion
- 2018-02-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.